---
title: "CVS Health's pre-market stock price fell over 5%, currently reported at $76.404"
description: "CVS Health's pre-market stock price fell over 5%, currently reported at $76.404"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/263530870.md"
published_at: "2025-10-30T13:18:20.000Z"
---

# CVS Health's pre-market stock price fell over 5%, currently reported at $76.404

CVS Health's pre-market stock price fell over 5%, currently reported at $76.404

### Related Stocks

- [CVS.US - CVS Health](https://longbridge.com/en/quote/CVS.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 西維斯健康展現出實力，因戰略調整提升了其健康保險和藥房業務 | CVS Health 正在顯示出改善的跡象，這得益於其在健康保險和零售藥房部門的戰略轉變。該公司正在將護理服務與保險產品整合，以增強其在動盪的醫療市場中的競爭地位。最近的財務結果表明利潤率擴張和收入穩定，同時供應鏈的改善和與支付方的合作也在 | [Link](https://longbridge.com/en/news/275574465.md) |
| 西維斯｜8-K：2025 財年 Q4 營收 1057 億美元超過預期 |  | [Link](https://longbridge.com/en/news/275449218.md) |
| 美股的 “危險信號” | 本月標普 500 指數成分股在八個交易日內下跌 7% 或以上的股票數量已經超過 100 只，直逼 2022 年美股熊市的水平。 雖然這不像新冠疫情或關税危機期間那樣極端，但該指標超過 100 通常意味着更大範圍的下滑，而這種情況目前還沒有發 | [Link](https://longbridge.com/en/news/276185288.md) |
| 美股盤前熱門交易：HCW Biologics 盤前漲 9.19%；Aprea Therapeutics 盤前跌 8.30% | HCW Biologics 盤前漲 9.19%；Aprea Therapeutics 盤前跌 8.30%；Mangoceuticals 盤前漲 67.42%；Opendoor Tech Series K - CW26 盤前漲 43.75%； | [Link](https://longbridge.com/en/news/276448801.md) |
| CVS Health 在 2025 年第四季度將 GAAP 每股收益提高到 2.30 美元，增長 76.9% | CVS Health 報告了其 2025 年第四季度財務業績的顯著增長，歸屬於股東的淨收入上升至 29.43 億美元，增長了 79%。稀釋每股收益達到 2.30 美元，增長 77%，而調整後的每股收益為 2.68 美元。該公司運營着大約 9 | [Link](https://longbridge.com/en/news/275448589.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.